Journal of Clinical Trials
Open Access

Department of Pharmacology, KLE University College of Pharmacy, Bengaluru, Karnataka, India

Publications

• Mini Review   
  A Short Review on Mucormycosis and its Risk in COVID-19 Patients
  Author(s): Sourav Guha and Deepika Pardhe*
  
  A life-threatening fungal infection known as mucormycosis occurs in immune compromised patients like patients having diabetic ketoacidosis, neutropenia, organ transplantation, increased serum levels of available iron etc. Mucormycosis is an emerging fungal infection worldwide, with devastating disease symptoms and diverse clinical manifestations. The most important underlying risk factors are immunosuppression, poorly controlled diabetes, iron overload and major trauma. The aetiological agents involved in the disease have been re-classified due to changes in taxonomy and nomenclature, which also led to appropriately naming the disease ‘mucormycosis’. This article shortly explains the new nomenclature, clinical manifestations and risk factors and focuses on putative virulence traits associated with mucormycosis, mainly in the group of diabetic ketoacido.. View More»
  

  Abstract PDF